tr1 cells Search Results


90
Merck KGaA tr1 cell line
Tr1 Cell Line, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tr1 cell line/product/Merck KGaA
Average 90 stars, based on 1 article reviews
tr1 cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
TxCell Inc tr1 cells
Clinical trials with Tregs
Tr1 Cells, supplied by TxCell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tr1 cells/product/TxCell Inc
Average 90 stars, based on 1 article reviews
tr1 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Charite Research Organisation ang ii type 1 (at1) receptors
Clinical trials with Tregs
Ang Ii Type 1 (At1) Receptors, supplied by Charite Research Organisation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ang ii type 1 (at1) receptors/product/Charite Research Organisation
Average 90 stars, based on 1 article reviews
ang ii type 1 (at1) receptors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
First Solar Inc series-7-tr1 series solar cells
Clinical trials with Tregs
Series 7 Tr1 Series Solar Cells, supplied by First Solar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/series-7-tr1 series solar cells/product/First Solar Inc
Average 90 stars, based on 1 article reviews
series-7-tr1 series solar cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Jackson Laboratory tr.1 cell line
Clinical trials with Tregs
Tr.1 Cell Line, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tr.1 cell line/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
tr.1 cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
TxCell Inc ova-tr1 cells
Clinical trials with Tregs
Ova Tr1 Cells, supplied by TxCell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ova-tr1 cells/product/TxCell Inc
Average 90 stars, based on 1 article reviews
ova-tr1 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Wolters Kluwer Health donor-specific tr1 cell–enriched product
Clinical trials with Tregs
Donor Specific Tr1 Cell–Enriched Product, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/donor-specific tr1 cell–enriched product/product/Wolters Kluwer Health
Average 90 stars, based on 1 article reviews
donor-specific tr1 cell–enriched product - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
StemCells Inc tr1 cells
Clinical trials with Tregs
Tr1 Cells, supplied by StemCells Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tr1 cells/product/StemCells Inc
Average 90 stars, based on 1 article reviews
tr1 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ROHHAD Fight Inc tr1 cell subset
Immunophenotype of PBMNC. The percentage of cells expressing different lineage markers for T cells (CD3, CD3/CD8, CD4, TCRαβ, TCRγδ), B cells (CD19), NK cells (CD16, CD56), regulatory B cells (Breg, CD19, CD38, and CD24), regulatory T cells (Treg, CD4, CD25, and CD127) and type 1 regulatory T cells <t>(Tr1,</t> CD4, CD45RO, LAG-3, and CD49b) has been evaluated by flow cytometry on PBMNC cells from patients affected by ROHHAD (n = 4, black squares), ROHHAD-NET (n = 4, gray triangles), and control individuals (n = 6, white dots). Results are expressed as number of cells/μL, which has been calculated as follows: (number of lymphocytes/μL × percentage of positive cells)/100. Horizontal bars indicated medians. P values are indicated where differences are statistically significant.
Tr1 Cell Subset, supplied by ROHHAD Fight Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tr1 cell subset/product/ROHHAD Fight Inc
Average 90 stars, based on 1 article reviews
tr1 cell subset - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Forschungszentrum gmbh smd1(83-119)-specific tr1 cells
Immunophenotype of PBMNC. The percentage of cells expressing different lineage markers for T cells (CD3, CD3/CD8, CD4, TCRαβ, TCRγδ), B cells (CD19), NK cells (CD16, CD56), regulatory B cells (Breg, CD19, CD38, and CD24), regulatory T cells (Treg, CD4, CD25, and CD127) and type 1 regulatory T cells <t>(Tr1,</t> CD4, CD45RO, LAG-3, and CD49b) has been evaluated by flow cytometry on PBMNC cells from patients affected by ROHHAD (n = 4, black squares), ROHHAD-NET (n = 4, gray triangles), and control individuals (n = 6, white dots). Results are expressed as number of cells/μL, which has been calculated as follows: (number of lymphocytes/μL × percentage of positive cells)/100. Horizontal bars indicated medians. P values are indicated where differences are statistically significant.
Smd1(83 119) Specific Tr1 Cells, supplied by Forschungszentrum gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/smd1(83-119)-specific tr1 cells/product/Forschungszentrum gmbh
Average 90 stars, based on 1 article reviews
smd1(83-119)-specific tr1 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Ferring Pharmaceuticals tr1 cells
Immunophenotype of PBMNC. The percentage of cells expressing different lineage markers for T cells (CD3, CD3/CD8, CD4, TCRαβ, TCRγδ), B cells (CD19), NK cells (CD16, CD56), regulatory B cells (Breg, CD19, CD38, and CD24), regulatory T cells (Treg, CD4, CD25, and CD127) and type 1 regulatory T cells <t>(Tr1,</t> CD4, CD45RO, LAG-3, and CD49b) has been evaluated by flow cytometry on PBMNC cells from patients affected by ROHHAD (n = 4, black squares), ROHHAD-NET (n = 4, gray triangles), and control individuals (n = 6, white dots). Results are expressed as number of cells/μL, which has been calculated as follows: (number of lymphocytes/μL × percentage of positive cells)/100. Horizontal bars indicated medians. P values are indicated where differences are statistically significant.
Tr1 Cells, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tr1 cells/product/Ferring Pharmaceuticals
Average 90 stars, based on 1 article reviews
tr1 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Kemper GmbH tr1 cells
Immunophenotype of PBMNC. The percentage of cells expressing different lineage markers for T cells (CD3, CD3/CD8, CD4, TCRαβ, TCRγδ), B cells (CD19), NK cells (CD16, CD56), regulatory B cells (Breg, CD19, CD38, and CD24), regulatory T cells (Treg, CD4, CD25, and CD127) and type 1 regulatory T cells <t>(Tr1,</t> CD4, CD45RO, LAG-3, and CD49b) has been evaluated by flow cytometry on PBMNC cells from patients affected by ROHHAD (n = 4, black squares), ROHHAD-NET (n = 4, gray triangles), and control individuals (n = 6, white dots). Results are expressed as number of cells/μL, which has been calculated as follows: (number of lymphocytes/μL × percentage of positive cells)/100. Horizontal bars indicated medians. P values are indicated where differences are statistically significant.
Tr1 Cells, supplied by Kemper GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tr1 cells/product/Kemper GmbH
Average 90 stars, based on 1 article reviews
tr1 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Clinical trials with Tregs

Journal: Biodrugs

Article Title: Cell-Based Therapies with T Regulatory Cells

doi: 10.1007/s40259-017-0228-3

Figure Lengend Snippet: Clinical trials with Tregs

Article Snippet: In 2012, TxCell company published results of therapy with Tr1 cells in refractory Crohn’s disease.

Techniques: Clinical Proteomics, Transplantation Assay, Injection

Immunophenotype of PBMNC. The percentage of cells expressing different lineage markers for T cells (CD3, CD3/CD8, CD4, TCRαβ, TCRγδ), B cells (CD19), NK cells (CD16, CD56), regulatory B cells (Breg, CD19, CD38, and CD24), regulatory T cells (Treg, CD4, CD25, and CD127) and type 1 regulatory T cells (Tr1, CD4, CD45RO, LAG-3, and CD49b) has been evaluated by flow cytometry on PBMNC cells from patients affected by ROHHAD (n = 4, black squares), ROHHAD-NET (n = 4, gray triangles), and control individuals (n = 6, white dots). Results are expressed as number of cells/μL, which has been calculated as follows: (number of lymphocytes/μL × percentage of positive cells)/100. Horizontal bars indicated medians. P values are indicated where differences are statistically significant.

Journal: Journal of the Endocrine Society

Article Title: Blood Lymphocyte Subsets and Proinflammatory Cytokine Profile in ROHHAD(NET) and non-ROHHAD(NET) Obese Individuals

doi: 10.1210/jendso/bvad103

Figure Lengend Snippet: Immunophenotype of PBMNC. The percentage of cells expressing different lineage markers for T cells (CD3, CD3/CD8, CD4, TCRαβ, TCRγδ), B cells (CD19), NK cells (CD16, CD56), regulatory B cells (Breg, CD19, CD38, and CD24), regulatory T cells (Treg, CD4, CD25, and CD127) and type 1 regulatory T cells (Tr1, CD4, CD45RO, LAG-3, and CD49b) has been evaluated by flow cytometry on PBMNC cells from patients affected by ROHHAD (n = 4, black squares), ROHHAD-NET (n = 4, gray triangles), and control individuals (n = 6, white dots). Results are expressed as number of cells/μL, which has been calculated as follows: (number of lymphocytes/μL × percentage of positive cells)/100. Horizontal bars indicated medians. P values are indicated where differences are statistically significant.

Article Snippet: Tr1 increase in our ROHHAD(NET) cohort could represent a consequence of the autoimmune activation in our patients, to be interpreted as an ineffective attempt to control such response, but this hypothesis needs to be confirmed.

Techniques: Expressing, Flow Cytometry, Control